On March 2, 2021 Qualigen Therapeutics, Inc. board elected Shishir Sinha as company Vice President, Chief Operating Officer and Secretary. (Mr. Sinha had previously been serving as company Vice President, Operations and Secretary. Chief Operating Officer is a newly-created officer position.). Mr. Sinha joined Qualigen as Vice President, Operations & QA/QC in 2006. Before joining Qualigen, Mr. Sinha held manufacturing and related positions with Nanogen, Celera Diagnostics, Sequenom, Sandoz Pharmaceutics (Novartis) and Microgenics Corp. There is no arrangement or understanding between Mr. Sinha and any other persons or entities pursuant to which he was elected to the new positions. His compensation is not being changed in connection with his election to his new positions.